Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon

NCT03600714 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

NIH

Sponsor class

Conditions

Liver Disease
Hepatitis D

Interventions

DRUG: Peg-interferon lambda
DRUG: Lonafarnib
DRUG: Ritonavir

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)